
Epofit 4000IU Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Recombinant Human Erythropoietin Alfa (4000IU)
Overview Epofit 4000IU Injection
Erythropoietin 4000IU Injection stimulates red blood cell production within the bone marrow. This medication addresses anemia stemming from kidney disease, cancer chemotherapy, or HIV medication. Administration, either subcutaneous or intravenous, is determined by your physician and typically performed by a healthcare professional. Dosage is weight-based and varies depending on the anemia's etiology. Concurrent iron supplementation can enhance treatment efficacy. Refrigerated storage is required, though the injection should reach room temperature before use. Common side effects, often subsiding after the initial treatment phase, may include nausea, vomiting, fever, hypertension, and influenza-like symptoms (headache, fatigue, dizziness, myalgia). Persistent side effects warrant medical consultation; immediate attention is required for seizures. Serious, potentially life-threatening blood clots are a possibility. Prior to commencing treatment, disclose any existing conditions such as uncontrolled hypertension, cardiovascular disease, or gout. Full disclosure of all current medications is essential. Regular blood pressure monitoring and routine blood tests are necessary to assess for adverse effects. The medication's impact on pregnancy is currently unknown; inform your physician if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Epofit 4000IU Injection
Managing Anemia in Cancer Patients Undergoing Chemotherapy | Addressing Anemia Associated with Chronic Kidney Failure
Major Benefits of Epofit 4000IU Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Epofit 4000IU Injection:
- High blood pressure
- Nausea
- Vomiting
- Fever
- Rash
- Joint pain
- Headache
- Insomnia (difficulty in sleeping)
- Chills
- Cough
- Bone pain
- Muscle spasm
- Dizziness
- Vascular occlusion
- Injection site irritation
- Stomatitis (Inflammation of the mouth)
- Weight loss
- Decreased white blood cell count (lymphocytes)
- Increased glucose level in blood
- Blood clot in the blood vessels
How to use Epofit 4000IU Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Epofit 4000IU Injection works:
Epofit 4000IU Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting the bone marrow, the blood cell-forming tissue within bones, to increase red blood cell generation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Epofit 4000IU Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Epofit 4000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to recommending this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Epofit 4000IU Injection while breastfeeding is likely inadvisable. Insufficient human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Epofit 4000 IU Injection may induce adverse reactions that could impair driving ability.
KidneySAFE IF PRESCRIBED
Epofit 4000IU Injection can be administered to patients with kidney disease without modification of the dosage. However, routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Epofit 4000IU Injection cautiously. Dosage modification of Epofit 4000IU Injection might be necessary. Seek medical advice before use.
What if you forget to take Epofit 4000IU Injection :
Omit a scheduled Epofit 4000IU Injection? Seek your physician's advice.
Facts to Know About Epofit 4000IU Injection
| Label | Value |
|---|---|
| Chemical Classification | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
